Brian Meldrum, M.B.B. Chir., Ph.D.

Dr. Meldrum is Emeritus Professor of Experimental Neurology, GKT School of Biomedical Sciences, Guy's Campus, Kings College, London.

Within the past three years, Dr. Meldrum has been a consultant to Sanofi-Synthelabo.

This activity is made possible by an unrestricted educational grant from Forest Laboratories.

Release Date: 04/27/2004
Termination Date: 04/27/2007

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Describe the roles of glutamate ionotropic receptors in epileptic discharges and the changes in glutamate receptor function in acquired epilepsy in animals and man
• Describe the anticonvulsant effects in animal models of AMPA and NMDA receptor antagonists
• Discuss the effects of selective glutamate metabotropic agents on seizure phenomena.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity